JP2022548698A5 - - Google Patents

Info

Publication number
JP2022548698A5
JP2022548698A5 JP2022517391A JP2022517391A JP2022548698A5 JP 2022548698 A5 JP2022548698 A5 JP 2022548698A5 JP 2022517391 A JP2022517391 A JP 2022517391A JP 2022517391 A JP2022517391 A JP 2022517391A JP 2022548698 A5 JP2022548698 A5 JP 2022548698A5
Authority
JP
Japan
Prior art keywords
polymer
group
integer
pharmaceutical composition
polymer according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022517391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548698A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051499 external-priority patent/WO2021055752A1/en
Publication of JP2022548698A publication Critical patent/JP2022548698A/ja
Publication of JP2022548698A5 publication Critical patent/JP2022548698A5/ja
Priority to JP2024202452A priority Critical patent/JP2025019142A/ja
Withdrawn legal-status Critical Current

Links

JP2022517391A 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法 Withdrawn JP2022548698A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024202452A JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962903332P 2019-09-20 2019-09-20
US62/903,332 2019-09-20
PCT/US2020/051499 WO2021055752A1 (en) 2019-09-20 2020-09-18 Benzoxaborole polymers and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024202452A Division JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Publications (2)

Publication Number Publication Date
JP2022548698A JP2022548698A (ja) 2022-11-21
JP2022548698A5 true JP2022548698A5 (enExample) 2023-09-28

Family

ID=74884685

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517391A Withdrawn JP2022548698A (ja) 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Country Status (4)

Country Link
US (1) US20220396651A1 (enExample)
EP (1) EP4041740A4 (enExample)
JP (2) JP2022548698A (enExample)
WO (1) WO2021055752A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4031553A4 (en) 2019-09-20 2023-11-01 Glyscend, Inc. POLYMERS WITH SUBSTITUTED PHENYLBORONIC ACID AND METHOD OF USE
AR134545A1 (es) * 2023-12-04 2026-01-28 Aviko Radiopharmaceuticals Llc Compuestos de arilo bicíclico fusionado para terapia de captura de neutrones en boro
TW202541817A (zh) * 2023-12-28 2025-11-01 美商艾維克放射性藥物股份有限公司 用於硼中子捕獲療法之稠合雙環芳基化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3413898B2 (ja) * 1993-09-14 2003-06-09 満 明石 高分子化合物およびその製造方法
CA2546696A1 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
US20110059176A1 (en) * 2007-11-22 2011-03-10 The University Of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture
EP3331499A4 (en) * 2015-08-06 2019-04-10 The Johns Hopkins University COMPOSITION AND METHOD FOR THE TREATMENT OF METABOLISM DISEASES
WO2017061435A1 (ja) * 2015-10-06 2017-04-13 国立研究開発法人物質・材料研究機構 ビニルアルコール樹脂機能化方法並びにビニルアルコール樹脂機能化剤
JP6630761B2 (ja) * 2018-03-06 2020-01-15 株式会社竹村製作所 樹脂管用継手
CN108478779B (zh) * 2018-04-12 2021-06-04 南京邮电大学 一种肿瘤靶向纳米药物及其制备方法和用途

Similar Documents

Publication Publication Date Title
ES3031577T3 (en) Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
JP6581625B2 (ja) 代謝障害を治療するための組成物および方法
Melson et al. Future therapies for obesity
CN110051638B (zh) 包含双胍的延迟释放组合物
US20220177532A1 (en) Compositions of peptide inhibitors of interleukin-23 receptor
KR101852044B1 (ko) 다기능성 쌍성이온 중합체 컨쥬게이트
ES2905690T3 (es) Polímeros que contienen zwitteriones de alto peso molecular
JP2023096079A (ja) 化合物の製剤およびそれらの使用
JP7691421B2 (ja) Ｇｌｐ２受容体アゴニストおよびその使用方法
AU2018255933A1 (en) Sustained release delivery systems comprising traceless linkers
JP2022548699A5 (enExample)
US20140357557A1 (en) Cyclodextrin-based polymers for therapeutic delivery
JP6704900B2 (ja) ポリオキサゾリン抗体薬物複合体
JP2013520561A5 (enExample)
JP2024514345A (ja) オリゴヌクレオチドの経口送達
JP2022501483A (ja) ボロン酸ポリマーおよび使用方法
JP2025019142A (ja) ベンゾオキサボロールポリマーおよび使用方法
JP2019514908A5 (enExample)
WO2023228023A1 (en) Treatment of type 2 diabetes or weight management control with 2-((4-((s)-2-(5-chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-benzo[d]imidazole-6-carboxylic acid or a pharmaceutically salt thereof
TWI335815B (en) Derivatives of asimadoline with covalently bonded acids
US12559553B2 (en) IL-31 modulators for treating FXR-induced pruritus
JP2008120708A (ja) フロリジン誘導体ならびにその製造方法
Gelb Safer Polymer Formulations for Stabilizing Protein Therapeutics
WO2025088570A1 (en) Ionizable lipids and ionizable lipid nanoparticles
HK40012109A (en) Delayed-release composition comprising biguanide